A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007197/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to evaluate the long-term safety and tolerability of
BIIB023 in participants with lupus nephritis (LN).
提供机构：
Vivli
创建时间：
2021-06-10
